EconomyLens.com
No Result
View All Result
Tuesday, June 17, 2025
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
EconomyLens.com
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
No Result
View All Result
EconomyLens.com
No Result
View All Result
Home Other

Who should get paid for nature’s sequenced genes?

Natalie Fisher by Natalie Fisher
October 30, 2024
in Other
Reading Time: 8 mins read
A A
0
35
SHARES
435
VIEWS
Share on FacebookShare on Twitter

Vanilla is grown in tropical regions of the world . ©AFP

Cali (Colombia) (AFP) – Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe. The plant’s sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers. Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

Related

Swiss insurers estimate glacier damage at $393 mn

Brazil sells exploration rights to oil blocks near Amazon river mouth

Taiwan tests sea drones as China keeps up military pressure

G7 leaders urge Trump to ease off trade war

Oil prices jump, stocks drop as traders track Israel-Iran crisis

“Wild genetic resources and pharmaceuticals … are a multi-multi-billion dollar businesses. They clearly are profitable … that’s not in dispute,” Charles Barber of the World Resources Institute think tank told AFP. “A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from” in the form of digitally sequenced data, he added. Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia. At the last conference, in Montreal in 2022, 196 country parties to the UN’s Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI). Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

– ‘Cheap and very fast’ –

The issue is a complex one. There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example. But how to quantify the value of the sequenced information itself? And should the first people to discover a plant’s particular usefulness be compensated?

“Sequencing technology has become so advanced that you can go with a … handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it,” Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP. These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development. DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

“Once the sequence is put into a public database, generally, no benefit-sharing obligations apply,” Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali. “Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood … with a cosmetic company or not, doesn’t matter.”

– Mandatory –

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics, or other products. They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

“We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory — the users should have some form of obligation to share benefits,” said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds. Developing countries want the information on genetic databases to be traceable and “answerable to governments” of the countries where it comes from, said Ramakrishnan. But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday. The World Wildlife Fund has said “many more rounds of negotiations appear necessary” on DSI. Added Barber: “I think it’s not going to all get solved here.”

© 2024 AFP

Tags: biodiversitygenetic resourcespharmaceuticals
Share14Tweet9Share2Pin3Send
Previous Post

Google reports strong growth driven by AI, cloud

Next Post

‘New wave’ as start-up sweeps up Thai ocean plastic

Natalie Fisher

Natalie Fisher

Related Posts

Other

Oil prices rally, stocks mixed as traders track Israel-Iran crisis

June 17, 2025
Other

Venezuela’s El Dorado, where gold is currency of the poor

June 17, 2025
Other

Oil prices jump after Trump’s warning, stocks extend gains

June 17, 2025
Other

Despite law, US TikTok ban likely to remain on hold

June 16, 2025
Other

OpenAI wins $200 mn contract with US military

June 16, 2025
Other

G7 leaders urge Trump to ease off trade war

June 17, 2025
Next Post

'New wave' as start-up sweeps up Thai ocean plastic

UK's Labour govt prepares to deliver decisive first budget

Beijing files WTO complaint over EU's new taxes on Chinese EVs

Bitcoin close to record as cautious markets eye US election

0 0 votes
Article Rating
Subscribe
Notify of
guest
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
  • Trending
  • Comments
  • Latest

New York ruling deals Trump business a major blow

September 30, 2024

Elon Musk’s X fights Australian watchdog over church stabbing posts

April 21, 2024

Women journalists bear the brunt of cyberbullying

April 22, 2024

France probes TotalEnergies over 2021 Mozambique attack

May 6, 2024

Ghanaian finance ministry warns against fallout from anti-LGBTQ law

74

New York ruling deals Trump business a major blow

72

Shady bleaching jabs fuel health fears, scams in W. Africa

71

Stock markets waver, oil prices edge up

65

US retail sales slip more than expected after rush to beat tariffs

June 17, 2025

Taiwan tests sea drones as China keeps up military pressure

June 17, 2025

G7 leaders urge Trump to ease off trade war

June 17, 2025

Oil prices rally, stocks slide as traders track Israel-Iran crisis

June 17, 2025
EconomyLens Logo

We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.

Pages

  • Home
  • About Us
  • Privacy Policy
  • Contact Us

Categories

  • Business
  • Economy
  • Markets
  • Tech
  • Editorials

Network

  • Coolinarco.com
  • CasualSelf.com
  • Fit.CasualSelf.com
  • Sport.CasualSelf.com
  • SportBeep.com
  • MachinaSphere.com
  • MagnifyPost.com
  • TodayAiNews.com
  • VideosArena.com
© 2025 EconomyLens.com - Top economic news from around the world.
No Result
View All Result
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials

© 2024 EconomyLens.com - Top economic news from around the world.